Eli Lilly and Co 2021 Guidance Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Lilly 2021 Guidance Call. (Operator Instructions) As a reminder, today's conference call is being recorded.
I would now like to turn the conference over to Sara Smith. Please go ahead.
Good morning. Thank you for joining us for Eli Lilly and Company's 2021 Financial Guidance Call. I'm Sara Smith, Director of Investor Relations. Joining me on today's call are Dave Ricks, Lilly's Chairman and CEO; Josh Smiley, Chief Financial Officer; Dr. Dan Skovronsky, President of Lilly Research Laboratories; Anne White, President of Lilly Oncology; Ilya Yuffa, President of Lilly Bio-Medicines; Mike Mason, President of Lilly Diabetes; and Jake Van Naarden, Chief Operating Officer, Loxo Oncology at Lilly. We're also joined by Lauren Zierke of the Investor Relations team.
During this conference call, we anticipate making projections and forward-looking statements based on our current expectations. Our actual results could differ materially due
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
